Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study
udgivet i: Journal of Clinical Oncology
dato for udgivelse: 2016-04-25
sprog: engelsk
main subject: tyktarmskræft, cetuksimab, metastatic colon cancer, irinotecan
Cites articles
There is nothing here
Artikel - wd:Q39821902